Gene interventions in the β-adrenergic system for treating heart failure

Seminars in Thoracic and Cardiovascular Surgery

Volumn 15, Issue 3, 2003, Pages 259-267

  Parsa, Cyrus J ^a   Koch, Walter J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Desensitization; Gene therapy; Heart failure; adrenergic receptors

Indexed keywords

ADENOVIRUS VECTOR; BETA ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; ISOPRENALINE; LIM PROTEIN; PHOSPHOTRANSFERASE INHIBITOR;

ADRENERGIC SYSTEM; CAUSE OF DEATH; DRUG RESPONSE; GENE FUNCTION; GENE THERAPY; GENETIC MANIPULATION; HEART FAILURE; HEART FUNCTION; HUMAN; INOTROPISM; MORTALITY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

EID: 0141631511     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-0679(03)70005-7     Document Type: Article

References (69)

1. Cohn JN, Bristow MR, Chien KR, et al: Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95: 766-770, 1997
2. Cohn JN, Levine TB, Olivari MT, et al: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819-823, 1984
3. Bristow M, Port JD: β-Adrenergic blockade in chronic heart failure. Scand Cardiovasc J 47(suppl):45-55, 1998
4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol GR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001-2007, 1999
5. Packer M, Bristow MR, Cohn JN, et al: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U. S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355, 1996
6. Rockman HA, Koch WJ, Lefkowitz RJ: Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212, 2002
7. Iaccarino G, Lefkowitz RJ, Koch WJ: Myocardial G protein-coupled receptor kinases: Implications for heart failure therapy. Proc Assoc Am Physicians 111:399-405, 1999
8. Pierce KL, Premont RT, Lefkowitz RJ: Seven-transmembrane receptors. Mol Cell Biol 3:639-650, 2002
9. Brodde OE: β-Adrenoceptors in cardiac disease. Pharmacol Ther 60:405-430, 1993
10. 2 adrenergic receptor mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol 35:295-303, 1989
11. Steinberg SF: The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85:1101-1111, 1999
12. Engelhardt S, Hein L, Wiesmann F, et al: Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96:7059-7064, 1999
13. Communal C, Singh K, Sawyer DB, et al: Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein. Circulation 100:2210-2212, 1999
14. 2-adrenergic receptor. Science 264:582-586, 1994
15. Zhu WZ, Zheng M, Koch WJ, et al: Dual modulation of cell survival and cell death by β2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98:1607-1612, 2001
16. αq overexpressing mice. Proc Natl Acad Sci USA 96:6400-6405, 1999
17. Bristow MR, Ginsburg R, Umans V, et al: β1- and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective β1-receptor down- regulation in heart failure. Circ Res 59:297-309, 1986
18. Bristow MR, Ginsburg R, Minobe W, et al: Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205-211, 1982
19. Liggett SB, Wagoner LE, Craft LL, et al: The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102:1534-1539, 1998
20. 2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347: 1135-1142, 2002
21. Ungerer M, Bohm M, Elce JS, et al: Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87:454-463, 1993
22. Feldman AM: Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. Circulation 87:IV27-IV34, 1993
23. i proteins and its physiological relevance in murine cardiac myocytes. Circ Res 84:43-52, 1999
24. Daaka Y, Pitcher JA, Richardson M, et al: Receptor and Gβγ isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci USA 94:2180-2185, 1997
25. Maurice JP, Shah AS, Kypson AP, et al: Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol 276:H1853-H1860, 1999
26. Choi D-J, Koch WJ, Hunter JJ, Rockman HA: Mechanism for β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. J Biol Chem 272:17223-17229, 1997.
27. Ungerer M, Kessebohm K, Kronsbein K, et al: Activation of β-adrenergic receptor kinase during myocardial ischemia. Circ Res 79:455-460, 1996
28. Gros R, Benovic JL, Tan M, Feldman RD: G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 99:2087-2093, 1997
29. Koch WJ, Rockman HA, Samama P, et al: Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268:1350-1353, 1995
30. Koch WJ, Inglese J, Stone WC, et al: The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J Biol Chem 268:8256-8260, 1993
31. Jaber M, Koch WJ, Rockman HA, et al: Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci USA 93:12974-12979, 1996
32. Rockman HA, Akhter SA, Choi D-J, et al: Regulation of myocardial contractile function by the level of β-adrenergic receptor kinase-1 in gene targeted mice. J Biol Chem 273:18180-18184, 1998
33. Rockman HA, Chien KR, Choi D-J, et al: Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of heart failure in gene targeted mice. Proc Natl Acad Sci USA 95:7000-7005, 1998.
34. Freeman K, Olsson MC, Iaccarino G, et al: Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 107:967-974, 2001
35. Harding V, Jones L, Lefkowitz RJ, et al: Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci USA 98:5809-5814, 2001
36. A133 expression. J Mol Cell Cardiol 34:669-677, 2002
37. Symes JF, Losordo DW, Vale PR, et al: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68:830-836, 1999
38. Rosengart TK, Lee LY, Patel SR, et al: Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474, 1999
39. Hajjar RJ, del Monte F, Matsui T, Rosenzweig A: Prospects from gene therapy for heart failure. Circ Res 616-621, 2000
40. Hoshijima M. Ikeda Y, Iwanaga Y, et al: Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 864-871, 2002.
41. Lai NC, Roth DM, Gao MH, et al: Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation 102:2396-2401, 2000
42. Roth DM, Bayat H, Drumm JD, et al: Adenylyl cyclase increases survival in cardiomyopathy. Circulation 105: 1989-1994, 2002
43. Akhter SA, Skaer CA, Kypson AP, et al: Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci USA 94:12100-12105, 1997
44. Drazner MH, Peppel KC, Dyer S, et al: Potentiation of β-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. J Clin Invest 99:288-296, 1997
45. Eckhart AD, Koch WJ: Expression of a β-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes. Mol Ther 5:74-79, 2002
46. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239-4242, 1990
47. Lin H, Parmacek MS, Morle G, et al: Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82:2217-2221, 1990
48. Buttrick PM, Kass A, Kitsis RN, et al: Behavior of genes directly injected into the rat heart in vivo. Circ Res 70:193-198, 1992
49. Duckers HJ, Nabel EG: Prospects for genetic therapy of cardiovascular disease. Med Clin North Am 84:199-213, 2000
50. Leiden JM: Human gene therapy: The good, the bad, and the ugly. Circ Res 86:923-925, 2000
51. Maurice JP, Hata JA, Shah AS, et al: Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery. J Clin Invest 104:21-29, 1999
52. Miyamoto MI, del Monte F, Schmidt U, et al: Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97:793-798, 2000
53. Amalfitano A, Parks RJ: Separating fact from fiction: Assessing the potential of modified adenovirus vectors for use in human gene therapy. Curr Gene Ther 2:111-133, 2002
54. Kawahira Y, Sawa Y, Nishimura M, et al: Gene transfection of β2-adrenergic receptor into the normal rat heart enhances cardiac response to β-adrenergic agonist. J Thorac Cardiovasc Surg 118:446-451, 1999
55. Kypson AP, Peppel K, Akhter SA, et al: Ex vivo adenovirus-mediated gene transfer to the adult rat heart. J Thorac Cardiovasc Surg 115:623-630, 1998
56. Kypson A, Hendrickson S, Akhter S, et al: Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function. Gene Ther 6:1298-1304, 1999
57. Kawahira Y, Sawa Y, Nishimura M, et al: In vivo transfer of a β2-adrenergic receptor gene into the pressure-overloaded rat heart enhances cardiac response to beta-adrenergic agonist. Circulation 98:II262-II267, 1998
58. Tevaearai HT, Eckhart AD, Walton GB, et al: Myocardial gene transfer and overexpression of β2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 106:124-129, 2002
59. Shah AS, White DC, Tai O, et al: Adenovirus-mediated genetic manipulation of the myocardial β-adrenergic signaling system in transplanted hearts. J Thorac Cardiovasc Surg 120:581-588, 2000
60. Hajjar RJ, Schmidt U, Matsui T, et al: Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 95:5251-5256, 1998
61. White DC, Hata JA, Shah AS, et al: Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci USA 97:5428-5433, 2000
62. Tevaearai HT, Eckhart AD, Shotwell KF, et al: Ventricular dysfunction following cardioplegic arrest is improved after myocardial gene transfer of a β-adrenergic receptor kinase inhibitor. Circulation 104:2069-2074, 2001
63. 2-adrenergic receptor in the heart: Prospects for molecular ventricular assistance. Circulation 101:408-414, 2000
64. Shah AS, White DC, Emani S, et al: In vivo ventricular gene delivery of a β-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation 103:1311-1316, 2001
65. Emani SM, Shah AS, White DC, et al: Right ventricular gene therapy with a β-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding. Ann Thorac Surg 72:1657-1661, 2001
66. Davidson MJ, Jones JM, Emani SM, et al: Cardiac gene delivery with cardiopulmonary bypass. Circulation 104: 131-133, 2001
67. Jones JM, Wilson KH, Koch WJ, et al: Adenoviral gene transfer to the heart during cardiopulmonary bypass: Effect of myocardial protection technique on transgene expression. Eur J Cardiothorac Surg 21:847-852, 2002
68. Allen MD: Myocardial protection: Is there a role for gene therapy? Ann Thorac Surg 68:1924-1928, 1999
69. Bonatti J, Haeusler C, Klaus A, et al: Acceptance of gene therapy by the heart surgery patient. Eur J Cardiothorac Surg 21:981-986, 2002